Log In
BCIQ
Print this Print this
 

merimepodib

Also known as: VX-497

  Manage Alerts
Collapse Summary General Information
Company Vertex Pharmaceuticals Inc.
DescriptionInosine monophosphate dehydrogenase (IMPDH) inhibitor
Molecular Target Inosine monophosphate dehydrogenase (IMPDH)
Mechanism of ActionInosine monophosphate dehydrogenase (IMPDH) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat hepatitis C virus (HCV) infection
Regulatory Designation
PartnerTrek Therapeutics PBC

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/26/2016

Undisclosed

0

Undisclosed

Get a free BioCentury trial today